Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
PLUR Pluri Inc
- 6.750
- +1.950+40.63%
Close Apr 23 16:00 ET
- 6.800
- +0.050+0.74%
Post 20:01 ET
47.23MMarket Cap-1.83P/E (TTM)
7.130High5.000Low299.10KVolume5.000Open4.800Pre Close1.88MTurnover9.87%Turnover RatioLossP/E (Static)7.00MShares7.13052wk High-5.88P/B20.46MFloat Cap3.33052wk Low--Dividend TTM3.03MShs Float38400.000Historical High--Div YieldTTM44.38%Amplitude3.330Historical Low6.298Avg Price1Lot Size
About Pluri Inc Company
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Company Profile
SymbolPLUR
Company NamePluri Inc
Listing DateDec 10, 2007
Founded2001
CEOMr. Yaky Yanay
MarketNASDAQ
Employees118
Fiscal Year Ends06-30
AddressMATAM Advanced Technology Park,Building No. 5
CityHaifa
ProvinceHaifa
CountryIsrael
Zip Code3508409
Phone972-74-710-8600
Websitehttps://pluri-biotech.com/
Company Executives
- Name
- Position
- Salary
- Yaky Yanay
- Director, President and Chief Executive Officer
- 2.75M
- Liat Zalts
- Chief Financial Officer and Treasurer
- --
- Zami Aberman
- Chairman of the Board
- 123.69K
- Alejandro Weinstein
- Director
- --
- Maital Shemesh-Rasmussen
- Independent Director
- 44.00K
- Rami Levi
- Independent Director
- --
- Doron Birger
- Independent Director
- 45.42K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now